These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 11850706

  • 1. Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation.
    Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Wolf J, Nyström M, Hovi L.
    Bone Marrow Transplant; 2002 Jan; 29(2):121-7. PubMed ID: 11850706
    [Abstract] [Full Text] [Related]

  • 2. Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children.
    Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Peltola J, Hovi L.
    Cancer; 2005 Jan 01; 103(1):181-90. PubMed ID: 15540242
    [Abstract] [Full Text] [Related]

  • 3. Disturbed root development of permanent teeth after pediatric stem cell transplantation. Dental root development after SCT.
    Hölttä P, Hovi L, Saarinen-Pihkala UM, Peltola J, Alaluusua S.
    Cancer; 2005 Apr 01; 103(7):1484-93. PubMed ID: 15739206
    [Abstract] [Full Text] [Related]

  • 4. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
    Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P.
    Bone Marrow Transplant; 1999 Nov 01; 24(10):1131-6. PubMed ID: 10578163
    [Abstract] [Full Text] [Related]

  • 5. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
    Flandin I, Hartmann O, Michon J, Pinkerton R, Coze C, Stephan JL, Fourquet B, Valteau-Couanet D, Bergeron C, Philip T, Carrie C.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1424-31. PubMed ID: 16427213
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of bone marrow transplantation on dental status in children with leukaemia.
    Uderzo C, Fraschini D, Balduzzi A, Galimberti S, Arrigo C, Biagi E, Pignanelli M, Nicolini B, Rovelli A.
    Bone Marrow Transplant; 1997 Nov 01; 20(10):865-9. PubMed ID: 9404928
    [Abstract] [Full Text] [Related]

  • 7. Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy.
    Näsman M, Björk O, Söderhäll S, Ringdén O, Dahllöf G.
    Pediatr Dent; 1994 Nov 01; 16(3):217-23. PubMed ID: 8058547
    [Abstract] [Full Text] [Related]

  • 8. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
    George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L.
    J Clin Oncol; 2006 Jun 20; 24(18):2891-6. PubMed ID: 16782928
    [Abstract] [Full Text] [Related]

  • 9. Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.
    Saarinen-Pihkala UM, Hovi L, Koivusalo A, Jahnukainen K, Karikoski R, Sariola H, Wikström S.
    Pediatr Blood Cancer; 2012 Dec 15; 59(7):1190-7. PubMed ID: 22492714
    [Abstract] [Full Text] [Related]

  • 10. Disturbances in dental development and craniofacial growth in children treated with hematopoietic stem cell transplantation.
    Vesterbacka M, Ringdén O, Remberger M, Huggare J, Dahllöf G.
    Orthod Craniofac Res; 2012 Feb 15; 15(1):21-9. PubMed ID: 22264324
    [Abstract] [Full Text] [Related]

  • 11. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.
    Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, Foppiano F, Sacco O, Cabria M, De Marco R, Stella G, Dallorso S, Bagnasco F, Vitale V, Dini G, Haupt R.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1568-75. PubMed ID: 15990246
    [Abstract] [Full Text] [Related]

  • 12. Cataracts after autologous bone marrow transplantation in children.
    Frisk P, Hagberg H, Mandahl A, Söderberg P, Lönnerholm G.
    Acta Paediatr; 2000 Jul 01; 89(7):814-9. PubMed ID: 10943964
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation.
    Trahair TN, Vowels MR, Johnston K, Cohn RJ, Russell SJ, Neville KA, Carroll S, Marshall GM.
    Bone Marrow Transplant; 2007 Oct 01; 40(8):741-6. PubMed ID: 17724446
    [Abstract] [Full Text] [Related]

  • 14. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ, Huang DS, Wang JW, Feng C, Yang G.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr 01; 8(2):93-6. PubMed ID: 16613697
    [Abstract] [Full Text] [Related]

  • 15. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH, Cheung IY, Kramer K, Modak S, Cheung NK.
    Pediatr Blood Cancer; 2007 Apr 01; 48(4):430-4. PubMed ID: 16421906
    [Abstract] [Full Text] [Related]

  • 16. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT, Törnquist AL, Winiarski J.
    Acta Ophthalmol; 2008 May 01; 86(3):253-8. PubMed ID: 18093259
    [Abstract] [Full Text] [Related]

  • 17. Renal function after autologous bone marrow transplantation in children: a long-term prospective study.
    Frisk P, Bratteby LE, Carlson K, Lönnerholm G.
    Bone Marrow Transplant; 2002 Jan 01; 29(2):129-36. PubMed ID: 11850707
    [Abstract] [Full Text] [Related]

  • 18. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
    Hänel M, Kröger N, Sonnenberg S, Bornhäuser M, Krüger W, Kroschinsky F, Hänel A, Metzner B, Birkmann J, Schmid B, Hoffknecht MM, Fiedler F, Ehninger G, Zander AR.
    Ann Hematol; 2002 Feb 01; 81(2):96-102. PubMed ID: 11907790
    [Abstract] [Full Text] [Related]

  • 19. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients.
    Ruiz-Soto R, Sergent G, Gisselbrecht C, Larghero J, Ertault M, Hennequin C, Manson J, de Kerviler E, Briere J, Mounier N.
    Cancer; 2005 Dec 15; 104(12):2735-42. PubMed ID: 16284986
    [Abstract] [Full Text] [Related]

  • 20. Microdontia after chemotherapy in a child treated for neuroblastoma.
    Remmers D, Bökkerink JP, Katsaros C.
    Orthod Craniofac Res; 2006 Nov 15; 9(4):206-10. PubMed ID: 17101028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.